Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
ABIO: 165% | ARCA Biopharma shares are trading higher after the company and Oruka Therapeutics announced a merger agreement.
LGVC: 193% | LAMF Global Ventures Corp. I Shareholders Approve Previously Announced Business Combination with Nuvo Group Ltd.